Abstract
The "L"-shaped association between Body Roundness Index (BRI) and mortality indicates that BRI may serve as a useful indicator for evaluating mortality risk in patients with osteoporosis (OP), thereby informing clinical interventions and public health approaches.
Introduction
Osteoporosis (OP) is a systemic skeletal disease characterized by decreased bone mass and microarchitectural deterioration, leading to increased bone fragility and fracture risk. Traditionally, Body Mass Index (BMI) has been the standard for assessing weight-related health risks. However, BMI is often considered a blunt instrument as it fails to distinguish between lean mass, bone density, and fat distribution.
In osteoporotic populations, body composition is a critical determinant of health outcomes. This study investigates the Body Roundness Index (BRI)—a metric utilizing waist circumference and height to estimate visceral fat and body fat percentage—as a predictor of all-cause mortality in patients with OP.
Methods
This retrospective cohort study utilized data from the National Health and Nutrition Examination Survey (NHANES) cycles between 2005 and 2018. Participants aged 50 and older were included if they had a bone mineral density (BMD) T-score of $\le -2.5$ at the femoral neck or lumbar spine, measured via dual-energy X-ray absorptiometry (DXA).
BRI was calculated using a geometric formula based on an elliptical model of the human body. The primary outcome was all-cause mortality, analyzed using weighted Cox proportional hazards models and Restricted Cubic Splines (RCS) to identify non-linear associations.
Results
The final cohort consisted of 1,596 individuals. Over a median follow-up of 6.25 years, during which 31.1% of participants passed away, a significant "L-shaped" association was observed between BRI and mortality.
The Threshold Effect
Restricted Cubic Spline analysis identified a critical inflection point at a BRI of 5.
- Below BRI 5: There was a strong inverse relationship; every one-unit increase in BRI was associated with a 21% reduction in mortality risk (HR: 0.79).
- Above BRI 5: The protective effect plateaued and became statistically non-significant (HR: 0.97), suggesting a limit to the survival benefits of increased body roundness.
Furthermore, maximally selected rank statistics identified an optimal cutpoint of 4.07 for survival stratification. Participants in the "high BRI" group (>4.07) demonstrated significantly better long-term survival compared to the "low BRI" group.
Discussion: The Obesity Paradox in Osteoporosis
The findings support the "obesity paradox," where higher body mass appears protective in specific clinical populations. Several mechanisms may explain why a higher BRI is beneficial for osteoporotic patients:
- Mechanical Loading: According to Wolff’s Law, higher body weight exerts mechanical stress on bones, stimulating adaptive remodeling that increases bone density.
- Nutritional Buffer: Adipose tissue serves as a critical energy reserve during periods of acute illness or recovery from fractures.
- Hormonal Factors: Visceral fat facilitates the conversion of androgens into estrogens, which inhibit bone-resorbing cells (osteoclasts).
The protective effect was particularly pronounced in patients with cancer, likely due to BRI's role in buffering against cachexia (muscle wasting) and malnutrition.
Conclusion
In patients with osteoporosis, a higher BRI is associated with lower all-cause mortality up to a threshold of 5. Unlike the general population, where high BRI often signals cardiovascular risk, in this cohort, it appears to provide a survival advantage. BRI provides a more nuanced assessment than BMI and should be considered in clinical risk stratification for aging populations with bone health concerns.
This summary is based on research published in Frontiers in Nutrition.
Summary updated